Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Fitzgibbon

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Current Oncology (Toronto, Ont.)|August 5, 2014
The role of palliative chemotherapy in hospitalized patientsP Wheatley-Price, M Ali, K Balchin, et al.
Journal of Virology|December 1, 1993
Human immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugsJ E Fitzgibbon, A E Farnham, S J Sperber, et al.
AIDS Research and Human Retroviruses|March 1, 1991
In vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapyJ E Fitzgibbon, R M Howell, T A Schwartzer, et al.
Journal of Medical Virology|May 15, 1998
Effect of the HIV-1 syncytium-inducing phenotype on disease stage in vertically-infected childrenJ E Fitzgibbon, S Gaur, M Gavai, et al.
AIDS Research and Human Retroviruses|October 17, 2001
Emergence of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimensJ E Fitzgibbon, S Gaur, S M Walsman, et al.
The New England Journal of Medicine|December 16, 1993
Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutationJ E Fitzgibbon, S Gaur, L D Frenkel, et al.
Antiviral Research|August 12, 1999
A new contained human immunodeficiency virus type 1 host cell system for evaluation of antiviral activities of interferons and other agents in vitroM Moussazadeh, J Hua, M K Sidhu, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidineJ E Fitzgibbon, R M Howell, C A Haberzettl, et al.
AIDS Research and Human Retroviruses|November 1, 1991
In vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individualR M Howell, J E Fitzgibbon, M Noe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2003
A consensus development approach to define national research priorities in bone metastases: proceedings from NCIC CTG workshopJ Wu, A Bezjak, E Chow, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|August 5, 2014
The role of palliative chemotherapy in hospitalized patientsP Wheatley-Price, M Ali, K Balchin, et al.
Journal of Virology|December 1, 1993
Human immunodeficiency virus type 1 pol gene mutations in an AIDS patient treated with multiple antiretroviral drugsJ E Fitzgibbon, A E Farnham, S J Sperber, et al.
AIDS Research and Human Retroviruses|March 1, 1991
In vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapyJ E Fitzgibbon, R M Howell, T A Schwartzer, et al.
Journal of Medical Virology|May 15, 1998
Effect of the HIV-1 syncytium-inducing phenotype on disease stage in vertically-infected childrenJ E Fitzgibbon, S Gaur, M Gavai, et al.
AIDS Research and Human Retroviruses|October 17, 2001
Emergence of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimensJ E Fitzgibbon, S Gaur, S M Walsman, et al.
The New England Journal of Medicine|December 16, 1993
Transmission from one child to another of human immunodeficiency virus type 1 with a zidovudine-resistance mutationJ E Fitzgibbon, S Gaur, L D Frenkel, et al.
Antiviral Research|August 12, 1999
A new contained human immunodeficiency virus type 1 host cell system for evaluation of antiviral activities of interferons and other agents in vitroM Moussazadeh, J Hua, M K Sidhu, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1992
Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidineJ E Fitzgibbon, R M Howell, C A Haberzettl, et al.
AIDS Research and Human Retroviruses|November 1, 1991
In vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individualR M Howell, J E Fitzgibbon, M Noe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 24, 2003
A consensus development approach to define national research priorities in bone metastases: proceedings from NCIC CTG workshopJ Wu, A Bezjak, E Chow, et al.
Pageof 4